TTI-101 — Topline data
4Q 2026
4Q 2026: TTI-101 Phase 1b/2 HCC topline dataSource filing
TVARDI THERAPEUTICS INC · Data as of 2026-09-08
4Q 2026
4Q 2026: TTI-101 Phase 1b/2 HCC topline dataSource filing
2027
Phase 1b/2 IND submission expected 2027*Source filing